ANIP vs IP · rev $503.5M vs P/E 43, rev $11.97B
ANI Pharmaceuticals Inc (ANIP) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported IP revenue for 2026-06-30 was $11.97B. Net income was $48.0M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
ANIP currently screens at market cap $1.41B. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the ANIP and IP stock pages for the full models.
Not investment advice.